A. Papyan

690 total citations
9 papers, 535 citations indexed

About

A. Papyan is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, A. Papyan has authored 9 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in A. Papyan's work include Angiogenesis and VEGF in Cancer (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). A. Papyan is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). A. Papyan collaborates with scholars based in Germany and United Kingdom. A. Papyan's co-authors include Christiane J. Bruns, Ivan Ischenko, Karl‐Walter Jauch, Markus Guba, Gerald Schmid, Christian Graeb, Thomas Brückner, Hanns‐Peter Knaebel, Christoph M. Seiler and Henriette Golcher and has published in prestigious journals such as Blood, Annals of Surgery and International Journal of Cancer.

In The Last Decade

A. Papyan

9 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Papyan Germany	8	203	182	129	75	54	9	535
Eva Pokorná Czechia	13	153 0.8×	99 0.5×	82 0.6×	82 1.1×	43 0.8×	53	510
M. Walraven Netherlands	10	176 0.9×	114 0.6×	87 0.7×	106 1.4×	64 1.2×	11	563
Dario Fortunati Italy	10	197 1.0×	156 0.9×	155 1.2×	149 2.0×	17 0.3×	17	549
Yong‐Man Kim South Korea	10	246 1.2×	94 0.5×	99 0.8×	41 0.5×	32 0.6×	25	577
Lasse Langholm Denmark	8	146 0.7×	98 0.5×	80 0.6×	120 1.6×	27 0.5×	16	571
Hristina Obradović Serbia	14	170 0.8×	107 0.6×	82 0.6×	40 0.5×	28 0.5×	26	512
Jim‐Ray Chen Taiwan	15	231 1.1×	112 0.6×	182 1.4×	92 1.2×	55 1.0×	34	566
Bettina Schwarz Germany	14	193 1.0×	138 0.8×	217 1.7×	105 1.4×	37 0.7×	20	756
Zhengran Li China	16	140 0.7×	209 1.1×	73 0.6×	74 1.0×	22 0.4×	39	522
Jide Jin China	11	135 0.7×	78 0.4×	60 0.5×	53 0.7×	30 0.6×	29	404

Countries citing papers authored by A. Papyan

Since Specialization

Citations

This map shows the geographic impact of A. Papyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Papyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Papyan more than expected).

Fields of papers citing papers by A. Papyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Papyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Papyan. The network helps show where A. Papyan may publish in the future.

Co-authorship network of co-authors of A. Papyan

This figure shows the co-authorship network connecting the top 25 collaborators of A. Papyan. A scholar is included among the top collaborators of A. Papyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Papyan. A. Papyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Miksch, Rainer Christoph, Tobias S. Schiergens, Michael Thomas, et al.. (2019). Pancreatic panniculitis in acinar cell carcinoma of the pancreas with liver metastases. HPB. 21. S532–S533. 1 indexed citations

2.

Eichhorn, Martin, Ivan Ischenko, Sebastian Strieth, et al.. (2009). Vascular targeting by EndoTAG™‐1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer. International Journal of Cancer. 126(5). 1235–1245. 69 indexed citations

3.

Seiler, Christoph M., Thomas Brückner, Markus K. Diener, et al.. (2009). Interrupted or Continuous Slowly Absorbable Sutures For Closure of Primary Elective Midline Abdominal Incisions. Annals of Surgery. 249(4). 576–582. 165 indexed citations

4.

Ischenko, Ivan, Markus Guba, Maksim Yezhelyev, et al.. (2007). Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Angiogenesis. 10(3). 167–182. 44 indexed citations

5.

Schmid, Gerald, Markus Guba, Ivan Ischenko, et al.. (2007). The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1‐phosphate receptor 1. Journal of Cellular Biochemistry. 101(1). 259–270. 59 indexed citations

6.

Eichhorn, Martin, Sebastian Strieth, A. Papyan, et al.. (2007). Cationic lipid complexed camptothecin (EndoTAG®-2) improves antitumoral efficacy by tumor vascular targeting. Cancer Biology & Therapy. 6(6). 920–929. 29 indexed citations

7.

Schmid, G., Markus Guba, A. Papyan, et al.. (2005). FTY720 inhibits tumor growth and angiogenesis. Transplantation Proceedings. 37(1). 110–111. 33 indexed citations

8.

Guba, Markus, Maksim Yezhelyev, Martin Eichhorn, et al.. (2005). Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF. Blood. 105(11). 4463–4469. 109 indexed citations

9.

Bangard, Christopher, Axel Goßmann, A. Papyan, et al.. (2004). Magnetic resonance imaging in an orthotopic rat model: Blockade of epidermal growth factor receptor with EMD72000 inhibits human pancreatic carcinoma growth. International Journal of Cancer. 114(1). 131–138. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact